You searched for T cells - Page 20 of 41

In Depth 6 Nov 2024

Tuberculosis research: Are we finally close to developing a more effective treatment option?

…when we have the tools to prevent it, detect it, and treat it,” WHO director-general Tedros Adhanom Ghebreyesus told reporters at the time the report was released. Having said that,…

November 6, 2024 - 12 minutesmins - By Willow Shah-Neville

News and Trends 16 Sep 2024

Vironexis’ AAV vector approach: The next frontier in cancer immunology?

…relatively straightforward: use AAV vectors to instruct the liver to secrete a therapeutic protein that guides T cells to recognize and attack cancer cells. This approach not only simplifies the…

September 16, 2024 - 6 minutesmins - By Jules Adam

News and Trends 9 Jan 2023

Cartherics granted first patent in China

…other immune cells. The company is also developing autologous CAR-T cell therapies. These use the patient’s own immune system T-cells, which are modified to be effective against the patient’s cancer…

January 9, 2023 - 2 minutesmins - By Jim Cornall

Best in Biotech 17 Sep 2020

The Top 10 Biotech Companies Brewing at Oxford

…goal of exploiting TCR technology in the form of T-cell therapy. The company engineers the TCRs naturally present on the patient’s own immune T cells to improve their ability to…

September 17, 2020 - 8 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 19 Dec 2023

Nine biotech companies to watch in 2024

…involve precise engineering of cells within the body. This approach is different from traditional methods that typically modify cells outside the body and then reintroduce them. The company’s research targets…

December 19, 2023 - 12 minutesmins - By Jules Adam

News and Trends 1 May 2019

Next-Generation CAR-T Therapy Shows Promise in Child’s Neuroblastoma

…For the therapy tested in this trial, Cell Medica is using the patient’s own cells to manufacture each treatment. In the future, however, the company plans to test an off-the-shelf…

May 1, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

imcyse type 1 diabetes insulin immunotherapy

News and Trends 28 Aug 2019

Type 1 Diabetes Immunotherapy Shows Promise in Phase I

…cytolytic T cells to watch out for and kill the autoimmune cells without harming other parts of the immune system. Recently diagnosed patients are the ones most likely to benefit,…

August 28, 2019 - 3 minutesmins - By Jonathan Smith

Interview Mark Post cultured meat Mosa Meat

Interview 24 Apr 2017

‘Meat’ the Founder behind the Lab-Grown Burger Investors are Queuing for

…and muscle cells. That’s part of the plans for the near future, but we haven’t ventured into that yet. Because it not only requires co-culture. It also requires a bigger…

April 24, 2017 - 7 minutesmins - By Clara Rodríguez Fernández

News and Trends 20 Mar 2019

Czech Cell Therapy Increases Survival in Ovarian Cancer by 62%

…already in the market make use of immune T cells, engineering them to target a specific cancer antigen. With its dendritic cell therapy, Sotio aims to target different kinds of…

March 20, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

Harnessing antibody-drug conjugates (ADCs) in oncology: Pathways to clinical success

…technology undergoes refinement, the scope of targetable cancers expands. The hope is that next-generation ADCs can effectively go on to develop personalized oncology therapies that can treat previously untreatable tumors….

November 26, 2024 - 8 minutesmins - By Will Chu

Sanofi drops amcenestrant clinical development program

News and Trends 2 Aug 2022

Defence Therapeutics says AccuTOX kills cancer cells

…cancer cells is a significant advancement and development for oncology cancer treatment applications with Accum,” said Sebastien Plouffe, CEO of Defence Therapeutics. “Discovering that AccuTOX can behave as a chemotherapeutic…

August 2, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 22 Jun 2018

Next-Generation CAR-T Company Raises €130M on NASDAQ IPO

…severe inflammatory reaction CAR-Ts that is known to have killed patients in clinical trials with CAR-T cells. In Phase I trial run at UCL, the treatment showed similar efficacy to…

June 22, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: T cells

Tuberculosis research: Are we finally close to developing a more effective treatment option?

Vironexis’ AAV vector approach: The next frontier in cancer immunology?

Cartherics granted first patent in China

The Top 10 Biotech Companies Brewing at Oxford

Nine biotech companies to watch in 2024

Next-Generation CAR-T Therapy Shows Promise in Child’s Neuroblastoma

Type 1 Diabetes Immunotherapy Shows Promise in Phase I

‘Meat’ the Founder behind the Lab-Grown Burger Investors are Queuing for

Czech Cell Therapy Increases Survival in Ovarian Cancer by 62%

Harnessing antibody-drug conjugates (ADCs) in oncology: Pathways to clinical success

Defence Therapeutics says AccuTOX kills cancer cells

Next-Generation CAR-T Company Raises €130M on NASDAQ IPO

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!